"Low-dose doxycycline demonstrated similar effectiveness to high-dose therapy in managing lymphocytic scarring alopecia while ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

Cyprium Therapeutics, our subsidiary company that developed CUTX-101, will retain 100% ownership over any FDA Priority Review Voucher that may be issued at NDA approval. Clinical Updates Coronado ...

Fortress Biotech, Inc. (FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product ...

LIXTE Biotechnology (LIXT ... cells can be eliminated by treatment with LIXTE’s proprietary compound LB-100. “In addition to our ongoing clinical trials in ovarian and colorectal cancer ...

The downsizing is planned for May 12. — Cargo Therapeutics, 84 layoffs in San Carlos. The biotech company is halting development and is closing its San Carlos site. The downsizing is planned for ...

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings ... companies for our lead proprietary compound, LB-100, to treat ovarian and colorectal cancer,” said Bas ...

PASADENA, Calif, March 27, 2025 (GLOBE NEWSWIRE) -- LIXTE Biotechnology Holdings ... with two global pharmaceutical companies for our lead proprietary compound, LB-100, to treat ovarian and colorectal ...

Alcon's acquisition of Aurion Biotech enhances its cell therapy capabilities for eye diseases, with Aurion operating independently under Alcon's support. Aurion's AURN001, an allogeneic cell therapy ...

Artificial intelligence (AI) has taken the biotech industry by storm ... This funding took the total raised by the company to date to more than $100 million. Based in Paris, Iktos is making use of AI ...

We believe that Emrosi will become a major growth driver for Journey Medical, given its potential to achieve peak annual sales of an estimated $200 million in the United States, and $100 million ...

CINCINNATI (Cincinnati Business Courier) - A growing biotech and pharmaceuticals manufacturer that announced a large investment in Greater Cincinnati a little over a year ago has unveiled new ...